Bendamustine HCl
CAS No. | 3543-75-7 | Cat. No. | BCP02107 |
Name | Bendamustine HCl | ||
Synonyms | Bendamustine hydrochloride; Ribomustin;SDX-105;SDX 105;SDX105; EP-3101; EP 3101; EP3101; | ||
Formula | C16H22Cl3N3O2 | M. Wt | 394.72 |
Description | Bendamustine hydrochloride is the hydrochloride salt of bendamustine, a bifunctional mechlorethamine derivative with alkylator and antimetabolite activities. Bendamustine possesses three active moieties: an alkylating group; a benzimidazole ring, which may act as a purine analogue; and a butyric acid side chain. Although its exact mechanism of action is unknown, this agent appears to act primarily as an alkylator. Bendamustine metabolites alkylate and crosslink macromolecules, resulting in DNA, RNA and protein synthesis inhibition, and, subsequently, apoptosis. In October 2008, the FDA granted further approval to market Treanda for the treatment of indolent B-cell non-Hodgkin's lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. | ||
Related Products | 16506-27-7(Bendamustine) | ||
Pathways | Cell Cycle/DNA Damage | ||
Targets | DNA Alkylator/Crosslinker |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.